ADVANCE THE CELL & GENE THERAPY COLLECTIVE

WIPO WIPO 2020

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The International trademark ADVANCE THE CELL & GENE THERAPY COLLECTIVE was filed as Word mark on 10/04/2020 at the World Intellectual Property Organization.

Trademark Details Last update: July 27, 2023

Trademark form Word mark
File reference 1568388
Countries Canada United Kingdom
Base trademark US No. 90226712, September 30, 2020
Application date October 4, 2020
Expiration date August 1, 2022

Trademark owner

2 Bethesda Metro Center, Suite 850
Bethesda MD 20814
US

Trademark representatives

422 Morris Ave Summit NJ 07901 US

goods and services

35 Business management consulting services to the pharmaceutical and life sciences companies to provide advice and business strategies to conduct and manage research and clinical development of targeted therapies and diagnostics, clinical solutions, regulatory guidance, health economics design, launch planning, access strategy, promotional effectiveness, and market adoption; business management consultation in the field of promotion opportunity assessment, promotion effectiveness, payer promotion strategy, account manager and sales force promotion strategy and distribution strategy; business and management consulting services in the fields of healthcare, pharmaceuticals, biotechnology, medical devices, food and nutrition; public policy consulting services in the fields of healthcare, pharmaceuticals, biotechnology, medical devices, food and nutrition; business services provided to the healthcare industry, namely, the creation, collection, analysis, and reporting of health care data and information for support of business and public policy decision-making; provision of statistical and commercial and business information in the fields of healthcare, pharmaceuticals, biotechnology, medical devices, health insurance, food and nutrition
41 Providing online electronic publications, not downloadable, in the nature of informational reports for support of business and policy decisions for the healthcare industry
42 Scientific consulting services in the fields of healthcare, pharmaceuticals, biotechnology, medical devices, food and nutrition; scientific consulting services for the health insurance industry; provision of scientific research information in the fields of healthcare, pharmaceuticals, biotechnology, medical devices, health insurance, food and nutrition; providing medical and scientific research information in the field of clinical trials as they relate to healthcare, pharmaceuticals, biotechnology, medical devices and food and nutrition

Trademark history

Date Document number Area Entry
March 15, 2023 2023/16 Gaz US RAW: Total Ceasing Effect
January 24, 2023 2023/5 Gaz CA Rejection
April 13, 2022 2022/15 Gaz CA Rejection
August 12, 2021 2021/32 Gaz GB RAW: Rule 18ter(2)(i) GP following a provisional refusal
June 11, 2021 2021/25 Gaz Deletion
March 12, 2021 2021/11 Gaz GB Rejection
January 29, 2021 2021/6 Gaz EM Rejection
October 4, 2020 2020/51 Gaz US Registration

ID: 141568388